Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/13/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Samir Mitragotri

Wrong Dr. Samir Mitragotri?

Professor of Chemical Engineering...

University of California , Santa Barbara
5221 Cheadle Hall
Santa Barbara , California 93106
United States

Company Description: The University of California, Santa Barbara (UCSB) is one of 10 universities in the University of California system, and is one of only 62 research-intensive...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Ph.D. , Chemical Engineering
    Massachusetts Institute of Technology
  • Ph.D. , Chemical Engineering
    MIT
172 Total References
Web References
EnduRx - Scientific Advisory Board
www.endurxpharma.com, 3 Oct 2014 [cached]
Samir Mitragotri, Ph.D. Scientific Advisor
Dr. Mitragotri is a Professor of Chemical Engineering and the Director of the Center for Bioengineering at the University of California, Santa Barbara. Dr. Mitragotri is a leading researcher in the field of drug delivery. His research interests include the development of novel methods of drug delivery, including transdermal, oral and particle-based methods.
Dr. Mitragotri received his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and completed his fellowship with Dr. Robert Langer.
"Many diseases result in inflammation," ...
www.rdmag.com, 8 Jan 2015 [cached]
"Many diseases result in inflammation," said Samir Mitragotri, professor of chemical engineering at UC Santa Barbara and director of the campus's Center for Bioengineering. Whether inflammation is a byproduct of the disease or the inflammation is the disease, it is a common indicator of a problem with the system. "If we could target the common denominator, whether the inflammation is coming from cancer or arthritis, we could deliver the drug there," said Mitragotri, who specializes in targeted drug delivery.
...
"Basically the main benefit is that you can deliver the drug in a more effective dose," Mitragotri said. Take for example the case of chemotherapy, which often has a narrow therapeutic range: Too little and the treatment is not effective, too much and it can be lethal. Because chemo travels through the bloodstream and affects all the tissues it comes in contact with, dosages are restricted at least in part based on the deleterious effect it has on other, unafflicted organs and their functions. Not only can targeted therapy ensure other body systems remain unaffected, Mitragotri explained, but it could allow for higher doses of drug to the site, which could decrease treatment time.
Convoy Therapeutics
www.convoytx.com, 19 Nov 2014 [cached]
Convoy Therapeutics was founded in 2011, based on the proprietary Skin-Penetrating And Cell Entering (SPACE™) peptide technology invented by Professor Samir Mitragotri and his team at University of California, Santa Barbara.
Dr. Samir ...
www.convoytx.com, 10 Mar 2014 [cached]
Dr. Samir Mitragotri
...
Dr. Samir Mitragotri, Ph.D.
Chairman, Scientific Advisory Board
Dr. Mitragotri is a Professor of Chemical Engineering and the Director of the Center for Bioengineering at the University of California, Santa Barbara. Dr. Mitragotri is a leading researcher in the field of drug delivery. His research interests include the development of novel methods of drug delivery, including transdermal, oral and particle-based methods.
Dr. Mitragotri received his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and completed his fellowship with Dr. Robert Langer.
A team led by Samir ...
www.nature.com [cached]
A team led by Samir Mitragotri, a chemical engineer at the University of California, Santa Barbara, has demonstrated this strategy in principle in a study published this week in Proceedings of the National Academy of Sciences1.
...
"Essentially, they are liquids that can be used instead of organic solvents, which tend to be toxic," explains Mitragotri. "That's one of their main advantages for pharmaceutical applications."
Mitragotri and his team synthesized a variety of ionic liquids and screened them for their ability to penetrate skin and biofilms.
...
Mitragotri and colleagues are already thinking in that direction, "Given that ionic liquids show antibiotic activity, we can see applications wherever surfaces need to be treated."
...
The next step for Mitragotri and his team will be to expand the panel of target bacteria and test ionic liquids in vivo.
Other People with the name "Mitragotri":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304